Dong-E-E-Jiao Co., Ltd. — Investor Relations & Filings
Dong-E-E-Jiao Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine, with a primary focus on E-Jiao (donkey-hide gelatin) and its derivative products. The company’s core portfolio includes E-Jiao blocks, Fufang Ejiao Jiang, and various health supplements designed for blood nourishment and overall wellness. Recognized for its commitment to quality and heritage, the firm integrates a complete industrial chain encompassing donkey breeding, processing technology, and pharmaceutical manufacturing. It leverages modern scientific research to standardize traditional production methods, ensuring product efficacy and safety. Serving a broad consumer base seeking natural health solutions, the company maintains a dominant position in the tonic market through its focus on brand integrity and the preservation of national intangible cultural heritage.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第一期限制性股票激励计划首次授予激励对象名单(授予日) | 2025-06-18 | Chinese | |
| 北京金诚同达律师事务所关于东阿阿胶股份有限公司第一期限制性股票激励计划调整及首次授予事项的法律意见书 | 2025-06-18 | Chinese | |
| 第十一届监事会第八次会议决议公告 | 2025-06-18 | Chinese | |
| 第十一届董事会第九次会议决议公告 | 2025-06-18 | Chinese | |
| 上海荣正企业咨询服务(集团)股份有限公司关于东阿阿胶股份有限公司第一期限制性股票激励计划调整及首次授予相关事项之独立财务顾问报告 | 2025-06-18 | Chinese | |
| 监事会关于第一期限制性股票激励计划首次授予激励对象名单(授予日)的核查意见 | 2025-06-18 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42083946 | 第一期限制性股票激励计划首次授予激励对象名单(授予日) | 2025-06-18 | Chinese | ||
| 42083933 | 北京金诚同达律师事务所关于东阿阿胶股份有限公司第一期限制性股票激励计划调整及首次授予事项的法律意见书 | 2025-06-18 | Chinese | ||
| 42083914 | 第十一届监事会第八次会议决议公告 | 2025-06-18 | Chinese | ||
| 42083904 | 第十一届董事会第九次会议决议公告 | 2025-06-18 | Chinese | ||
| 42083890 | 上海荣正企业咨询服务(集团)股份有限公司关于东阿阿胶股份有限公司第一期限制性股票激励计划调整及首次授予相关事项之独立财务顾问报告 | 2025-06-18 | Chinese | ||
| 42083876 | 监事会关于第一期限制性股票激励计划首次授予激励对象名单(授予日)的核查意见 | 2025-06-18 | Chinese | ||
| 42083869 | 2024年年度权益分派实施公告 | 2025-05-26 | Chinese | ||
| 42083866 | 关于第一期限制性股票激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告 | 2025-05-20 | Chinese | ||
| 42083852 | 北京金诚同达律师事务所关于东阿阿胶股份有限公司2024年年度股东大会的法律意见书 | 2025-05-20 | Chinese | ||
| 42083841 | 2024年年度股东大会决议公告 | 2025-05-20 | Chinese | ||
| 42083830 | 关于参加2025年山东辖区上市公司投资者网上集体接待日活动的公告 | 2025-05-13 | Chinese | ||
| 42083824 | 监事会关于公司第一期限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见 | 2025-05-13 | Chinese | ||
| 42083812 | 北京市嘉源律师事务所关于华润医药投资有限公司增持东阿阿胶股份有限公司股份的法律意见书 | 2025-05-08 | Chinese | ||
| 42083799 | 关于控股股东之一致行动人增持公司股份计划实施完成的公告 | 2025-05-08 | Chinese | ||
| 42083773 | 第一期限制性股票激励计划(草案二次修订稿) | 2025-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Dong-E-E-Jiao Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53624/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53624 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53624 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53624 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53624}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dong-E-E-Jiao Co., Ltd. (id: 53624)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.